Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
The Pathogenetic Dilemma of Post-COVID-19 Mucormycosis in India
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The Pathogenetic Dilemma of Post-COVID-19 Mucormycosis in India'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antifungal Defense
33%
Aspergillus
33%
Biological Factors
33%
Candida
33%
CD8+ T Cells
33%
COVID-19
66%
COVID-19 Associated mucormycosis
100%
COVID-19 in India
33%
Dysglycemia
33%
Environmental Factors
66%
Fungal Pathogens
33%
Glucose-regulated Protein 78 (GRP78)
33%
Iatrogenic Factor
66%
India
100%
Invasive mucormycosis
33%
Mucormycosis
100%
Pneumocystis
33%
Probable Cause
33%
Spleen Tyrosine Kinase
33%
Two-hit
33%
Biochemistry, Genetics and Molecular Biology
Aspergillus
100%
Candida
100%
CD8
100%
Downregulation
100%
Infectious Agent
100%
Janus Kinase 1
100%
Pneumocystis
100%
Upregulation
100%
Immunology and Microbiology
Aspergillus
33%
Candida
33%
CD8
33%
COVID-19
100%
Downregulation
33%
Infectious Agent
33%
Pneumocystis
33%
Tyrosine
33%
Upregulation
33%
Pharmacology, Toxicology and Pharmaceutical Science
Antifungal Agent
20%
Aspergillus
20%
Candida
20%
CD8 Antigen
20%
Disease Predisposition
20%
Dysglycemia
20%
Infectious Agent
20%
Janus Kinase 1
20%
Mucormycosis
100%
Pneumocystis
20%
Protein Kinase Syk
20%